Phase II study of transarterial holmium-166-chitosan complex treatment in patients with a single, large hepatocellular carcinoma.

Sohn, Joo Hyuk; Choi, Hye Jin; Lee, Jong Tae; Lee, Jong Doo; Kim, Joo Hang; Moon, Young Myung; Park, Kyungsoo; Park, Kyung Bae; Kim, Eunhee; Yoo, Nae Choon

Sohn, Joo Hyuk; Choi, Hye Jin; Lee, Jong Tae; Lee, Jong Doo; Kim, Joo Hang; Moon, Young Myung; Park, Kyungsoo; Park, Kyung Bae; Kim, Eunhee; Yoo, Nae Choon.

Affiliation

Sohn JH; Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.

Oncology ; 76(1): 1-9, 2009.

Article in En | MEDLINE | ID: mdl-19018149

Subject(s)

Carcinoma, Hepatocellular/radiotherapy; Chitosan/therapeutic use; Holmium/therapeutic use; Radioisotopes/therapeutic use; Adult; Antineoplastic Agents/therapeutic use; Antineoplastic Agents/toxicity; Carcinoma, Hepatocellular/mortality; Chitosan/administration & dosage; Chitosan/toxicity; Dose-Response Relationship, Drug; Drug Administration Routes; Holmium/administration & dosage; Holmium/toxicity; Humans; Liver Function Tests; Models, Theoretical; Patient Selection; Radioisotopes/toxicity; Radiotherapy Dosage; Survival Rate; Young Adult

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radioisotopes / Carcinoma, Hepatocellular / Chitosan / Holmium Type of study: Prognostic_studies Limits: Adult / Humans Language: En Journal: Oncology Year: 2009 Document type: Article Country of publication: Switzerland

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google